This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Ceftazidime for Injection, USP (2015-07-27)
- Starting date:
- July 27, 2015
- Posting date:
- July 31, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-54480
Affected Products
Ceftazidime for Injection, USP
Reason
The repackaging procedure followed by Matrix may not have adequately protected the product from light during storage and distribution.
Depth of distribution
Shoppers Drug Mart pharmacies
Affected products
Ceftazidime for Injection, USP
DIN, NPN, DIN-HIM
DIN 00886971
Dosage form
Powder for solution
Strength
Ceftazidime 1 g / vial
Lot or serial number
All lots
Companies
- Recalling Firm
-
Shoppers Drug Mart Inc.,
Matrix Distribution Centre (Mississauga)
6941 Kennedy Road
Toronto
L5T 2R6
CANADA
- Marketing Authorization Holder
-
Fresenius Kabi Canada Ltd.
45 Vogell Rd, Ste 200
Richmond Hill
L4B 3P6
Ontario
CANADA